tradingkey.logo
搜尋

Arteris (AIP) 2026年第3季法說會:營收成長 48%,調升財測

2026年11月6日 00:02
facebooktwitterlinkedin

Arteris 公布 2026 年第三季營收達 2,580 萬美元,年增 48%,超越財測上緣。ACV 加計權利金達 1.04 億美元,年增 39%。剩餘履約義務達 1.35 億美元,管理階層預期略高於半數將於未來 12 個月內認列。Non-GAAP 營業虧損收斂至 120 萬美元。受惠於 AI 基礎設施與車用需求強勁,公司上修 2026 全年營收、ACV 及 Non-GAAP 營業表現財測。

該摘要由AI生成

重點摘要

  • Arteris 公布 2026 年第三季營收達創紀錄的 2,580 萬美元,年增 48%,超越其財測區間上緣。
  • ACV 加計權利金達到創紀錄的 1.04 億美元,年增 39%。過去 12 個月權利金年增 71%,達到創紀錄的 940 萬美元。
  • 剩餘履約義務達到 1.35 億美元。管理階層預計自 2026 年 10 月 1 日起的 12 個月內,將有略高於半數認列為營收。
  • Non-GAAP 營業虧損較去年同期收斂 230 萬美元至 120 萬美元。第四季展望介於 Non-GAAP 營業虧損 90 萬美元至營業利益 110 萬美元之間。
  • Arteris 上修 2026 全年營收、ACV 加計權利金以及 Non-GAAP 營業表現之財測。目前預期營收將介於 9,850 萬美元至 9,950 萬美元之間。
  • 小晶片專案約占新開案設計的 10%。管理階層預期該比例可能在未來兩到三年內達到約 30% 至 35%,同時強調多晶粒專案的平均售價高於單晶粒專案。

關鍵財務數據

指標2026 年第三季變動或說明
營收2,580 萬美元年增 48%;創歷史新高
ACV 加計權利金1.04 億美元年增 39%;創歷史新高
過去 12 個月權利金940 萬美元年增 71%;創歷史新高
剩餘履約義務1.35 億美元創歷史新高;預計略高於半數將在未來 12 個月內轉化為營收
Non-GAAP 毛利2,280 萬美元Non-GAAP 毛利率為 89%
GAAP 毛利2,230 萬美元GAAP 毛利率為 87%
Non-GAAP 營業費用2,400 萬美元費用成長受到 RSU 歸屬相關之法國薪資稅影響
Non-GAAP 營業虧損120 萬美元較去年同期改善 230 萬美元
GAAP 營業虧損1,130 萬美元—
Non-GAAP 淨虧損110 萬美元稀釋後每股虧損 0.02 美元
GAAP 淨虧損1,120 萬美元稀釋後每股虧損 0.23 美元
自由現金流負 210 萬美元主要受客戶付款時程影響
現金、約當現金及投資1.2 億美元截至季末無金融負債

業務與營運表現

在企業運算、車用、工業、消費性電子、通訊以及航太與國防領域的授權業務維持強勁。按金額計算,第三季有三分之一的設計定案來自全球前 30 大科技客戶。

Arteris 本季累計獲客戶確認的新開案設計突破 1,000 件。隨著客戶因應日益升高的半導體設計複雜度,該公司旗下四大系統 IP 產品線也獲得更廣泛的採用。

AI 基礎設施仍是主要需求驅動力。Arteris 在第三季簽署的最大合約,是一家頂尖超大規模雲端業者擴大將該公司技術應用於晶片與小晶片。兩家全球前十大半導體公司亦擴大導入,以支援 AI 加速器、資料中心運算以及用於代理型工作負載的 XPU。管理階層表示,這些應用涉及用於 AI 推論的客製化晶片。

實體 AI 需求正建立在 Arteris 的車用經驗之上。一家領先的車用 OEM 擴大採用 Arteris 技術於其多代自行研發的晶片中。管理階層表示,實體 AI 設計與車用領域具有相同的要求,包括效能、能源效率、功能安全以及資訊安全,不過機器人領域可能還需要額外的動作控制與感測器處理能力。

該公司藉由 FlexGen Multi-Die 與 Ncore Multi-Die 擴大其小晶片及多晶粒產品組合。這些產品旨在透過晶粒對晶粒連結擴展資料傳輸,使多個晶粒能以統一架構運作。Arteris 表示,每個小晶片都代表一個獨立專案與權利金收益來源,不過封裝層級的定價仍取決於客戶協商與折扣。

半導體資安是另一個重點。Arteris 在「受信與有保證微電子」倡議下,與貝宜系統及 SiFive 合作擴大其第三方 IP 計畫。管理階層打算將資安產品進一步推廣至商業客戶,同時也指出市場採用仍需時間。

管理階層財測

財測指標2026 年第四季2026 全年
ACV 加計權利金1.03 億美元至 1.07 億美元2026 年底達 1.03 億美元至 1.07 億美元;區間中位數較先前財測調升 100 萬美元
營收2,570 萬美元至 2,670 萬美元9,850 萬美元至 9,950 萬美元;較先前財測調升 250 萬美元
Non-GAAP 營業利益(虧損)虧損 90 萬美元至利益 110 萬美元虧損 920 萬美元至 720 萬美元;較先前財測改善 30 萬美元
Non-GAAP 自由現金流—正 500 萬美元至 900 萬美元;維持不變

管理階層重申其長期營運模式目標,即營業費用成長率約為營收成長率的一半。該公司表示,持續的產品研發與客戶成功投資將支援未來的營收成長,同時透過費用控管提升營運槓桿。

風險與關注事項

  • 由於交易時程會造成業績波動不均,ACV 加計權利金在各季之間可能呈現起伏。
  • 第三季自由現金流為負,主要受客戶付款時程影響。
  • RSU 歸屬相關的法國薪資稅推升了 2026 年的費用成長。
  • 資安產品普及需要時間,特別是 Arteris 正尋求從政府相關專案拓展至商業客戶。
  • 小晶片專案的經濟效益取決於客戶協商,包括單一封裝包含多個小晶片時的折扣條件。

分析師問答重點

管理階層估計,2026 年片上網路合約的平均售價約為 100 萬美元。若客戶同時採用整合自動化與資安產品,可能會增加約 40 萬至 45 萬美元,使廣泛的多產品合作專案總額達到約 140 萬至 150 萬美元。

小晶片設計目前約占新開案設計的 10%。管理階層認為,該比例在未來兩到三年內可能上升至約 35% 或更高。每個小晶片都能產生各自的專案費用與權利金收益,使多晶粒方案比傳統單晶粒專案更具價值,不過定價仍採逐案依封裝協商。

在獲利能力方面,管理階層維持營業費用成長速度應約為營收成長速度一半的看法。該公司表示對費用具有良好的掌握度,並在討論改善後的第四季展望時提及該架構。

Arteris 亦強調客戶與應用範疇的多元化。管理階層指出,過去幾季中,沒有任何單一客戶占營收比重超過 10%。

完整法說會逐字稿


完整財報電話會議逐字稿

管理層陳述

Operator

Good afternoon, everyone, and welcome to the Arteris Third Quarter 2026 earnings call. Please note this call is being recorded and simultaneously webcast. All material contained in the webcast is a sole property and copyright of Arteris, with all rights reserved. For opening remarks and introductions, I will now turn the call over to Erica Mannion at Sapphire Investor Relations.

Erica Mannion

Thank you and good afternoon. With me today from Arteris are Charlie Janac, Chief Executive Officer, and Saurabh Sinha, Chief Financial Officer. Charlie will begin with a brief review of the business results for the third quarter ended September 30, 2026. Saurabh will review the financial results quarter of 2026, followed by the company's outlook for the fourth quarter and the full year of 2026. We will then open the call for questions. Before we begin, I'd like to remind listeners that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements are based on management's current expectations and assumptions and involve material risks and uncertainties that could cause actual results or events to differ materially from those anticipated and you should not place undue reliance on forward-looking statements. Additional information regarding these risks, uncertainties, and factors that could cause results to differ appear in the press release Arteris issued today and in the documents and reports filed by Arteris from time to time with the Securities and Exchange Commission.

Please note, during this call, management will cite certain non-GAAP measures, including, among others, non-GAAP net loss, non-GAAP net loss per share, and free cash flow, which are not measures prepared in accordance with U.S. GAAP. The non-GAAP measures are presented as we believe that they provide investors with a means of evaluating and understanding how the company's management evaluates the company's operating performance. These non-GAAP measures should not be considered in isolation from, as substitutes for, or superior to financial measures prepared in accordance with U.S. GAAP. A reconciliation of these non-GAAP measures to the nearest GAAP measure can be found in the press release for the quarter ended September 30, 2026. In addition, for a definition of certain of the key performance indicators used in this presentation, as annual contract value and remaining performance obligations, please see the press release for the quarter ended September 30, 2026. These key performance indicators are presented for supplemental informational purposes only, should not be considered a substitute for financial information presented in accordance with GAAP, and may differ from similarly titled metrics or measures used by other companies, securities analysts, or investors. Listeners who do not have a copy of the press release for the quarter ended September 30, 2026 may obtain a copy by visiting the investor relations section of the company's website.

In addition, management will be referring to the third quarter 2026 earnings presentation, which can be found in the investor relations section of the company's website under the events and presentations tab. Before I turn the call over to Charlie, I would like to mention that management will participate in the Roth Technology Conference on November 18 in New York and the Northland Growth Conference on December 16, which takes place virtually. Now I will turn the call over to CEO, Charlie Janik.

Karel Janac

Thank you, Erica, and thanks to everyone for joining us on our call today. In the third quarter, we achieved another record annual contract value plus royalties of $104 million, representing a 39% year-on-year increase, and record revenue of 25.8 million, representing a 48% increase. Once again, we also achieved record royalties and RPO backlog. Licensed activity in the quarter remains strong, supported by the continuing integration of data center edge and physical AI computing. We are seeing this across all market verticals led by enterprise computing, followed by automotive, industrial, consumer electronics, communications, and aerospace and defense applications. A third of those wins in dollar terms were with top 30 global technology customers. Demonstrating strong market momentum, a growing number of customers are deploying multiple products from our four system IP product lines.

This multi-product adoption reflects the critical role our solutions play in managing rising semiconductor design complexity. During the quarter, Arteris surpassed 1,000 customer-confirmed design starts. Arteris is increasingly becoming a key partner in the rapidly evolving semiconductor market spanning the world's largest established technology companies through the most innovative startups. By enabling the underlying high performance, efficient, safe and secure data movement in silicon devices, Arteris has been able to support innovation from the smartphone inflection to today's deployments in sophisticated and complex AI infrastructure silicon, intelligent edge devices, and physical AI. Surpassing 1,000 customer-confirmed design starts demonstrates continued customer confidence in our products and our customer success organization. AI infrastructure semiconductor design activity remains strong in Q3 with a growing demand for Arteris products that help enable the underlying data movement in chips and chiplets. In the third quarter, our largest deal was with a top hyperscaler who expanded their existing use of Arteris technology to accelerate the creation and integration of chips and chiplets.

In addition, two of the industry's top 10 semiconductor companies expanded their usage of our products to support their existing AI accelerators and data center compute needs, as well as the growing demands for architecture across XPUs for agentic workloads and other applications. Physical AI is another area where we continue to see growing demand for our Arteris products. Building upon our proven technology in automotive and autonomous systems, customers are able to scale our solutions to drones, humanoid robotics, and adjacent applications. In the third quarter, one of our largest deals came from a leading automotive OEM, which expanded the use of our Arteris technology for successive generations of their in-house advanced chip designs, where performance, energy efficiency, safety, and security are crucial. Another highlight of the third quarter was our announcement of the expansion of our chiplet and multi-die solution. The silicon design sophistication continues to grow across applications. The required physical semiconductor area becomes quite large, creating design, manufacturing, and yield challenges.

As a result, the development of chiplets and their integration into multi-die SOCs is accelerating. This in turn introduces the challenge of addressing die-to-die communication and data movement that previously occurred seamlessly within one chip, now having to cross physical boundaries while maintaining performance efficiency and predictable traffic behavior. The expansion of our chiplet and multi-die solution addresses this challenge. by extending data movement across die to die links, allowing multiple dies to operate as a unified architecture. The new FlexGen Multi-Die and Encore Multi-Die products expand the Arteris solution to support chiplet architectures. These increasingly include solutions for agentic AI workflows, HPC, data center, cloud infrastructure, physical AI, and others. Together with Arteris Magellan IP Integration Automation and Cycuity Hardware Security Assurance, our expanded portfolio provides semiconductor engineering teams with technologies spanning data movement, system integration, and cybersecurity for increasingly complex multi-die designs. These new products are a direct result of close collaboration with customers such as AMD and Socionext and ecosystem partners including Cadence, Siletronics, Synopsys, Univista and others.

Chiplets, multi-die systems, AI infrastructure, and physical AI also increasingly require semiconductor cybersecurity assurance. The growing security threats posed by fast-evolving frontier AI models identification and exploitation of vulnerabilities are driving new and growing cybersecurity standards compliance requirements. This results in growing interest and demand for our security semiconductor cybersecurity assurance products. During the third quarter, we announced the expansion of the third party IP program as part of the trusted and assured microelectronics program. This program, driven in close collaboration by BAE Systems and Sci-5, aims to address the growing challenge of ensuring the security and trustworthiness of commercially sourced third party silicon IP, cybersecurity assurance methodologies for semiconductors used in mission critical systems enabled by our products. Our customers continue to innovate in exciting high-growth areas, which require a combination of high performance, efficiency, safety, and security, backed by global customer support. Arteris continues to be in an excellent position to support demand for advanced semiconductor technologies in the AI era, infrastructure silicon, edge devices, and physical AI systems.

Our focus remains on enabling customers to accelerate their innovation while reducing development risks to bring their next generation products to market with Arteris technology at its core. Lastly, I will hand the call over to our new CFO, Saurabh Sinha brings more than 25 years of financial leadership experience at public and high-growth technology companies, and we're excited to have him on board. With that, I will turn it over to Saurabh to discuss our financial results in detail.

Saurabh Sinha

Thank you, Charlie. Good afternoon, everyone. Since joining Arteris in September, I have spent the past few weeks integrating with the team and diving deep into our operations. It is a privilege to step into the company at such a pivotal moment in its growth. I look forward to collaborating closely with the team to capture the significant opportunities ahead and drive long-term value for both customers and shareholders. As I review our Q3, 2026 results, I will refer to both GAAP and non-GAAP financial measures. The earnings release posted on our website includes a reconciliation of the non-GAAP measures to their most directly comparable GAAP measures. I will also refer to the Q3 earnings presentation, which is available in the investor relations section of our website under events and presentation.

We delivered another quarter of solid financial results, and in Q3 we exceeded or met our guidance on revenue and other key KPIs. Turning to slide five, Q3 revenue was 25.8 million, up 48% from a year ago, and exceeding the top end of our guidance range. At quarter end, ACV plus royalties totaled 104 million, up 39% year-over-year, and also exceeding the top end of our guidance. Setting another record, trailing 12-month royalties were 9.4 million, up 71% year-over-year, and also a record high. Remaining performance obligations, or RPO, which represents contracted future revenue, totaled 135 million at quarter end, another record for Arcturus. We expect slightly more than half of this amount to be recognized as revenue during the 12 months beginning October 1, 2026. Non-GAAP gross profit was 22.8 million for a non-GAAP gross margin of 89%.

GAAP gross profit was 22.3 million for a GAAP gross margin of 87%. As a reminder, 2026 gross margin includes subcontractor costs in cost of revenue for certain security government contracts. Now to slide six, non-GAAP operating expenses in the quarter were 24 million. As mentioned in previous calls, expense growth has been impacted this year by French payroll taxes associated with RSU vesting. Our long-term operating model objective is to grow operating expenses at approximately half the rate of revenue growth, and our Q3 revenue and operating expense results are consistent with that model. As always, our continued investment in product development and customer success will support revenue growth over the coming years. Total GAAP operating expenses for Q3 were 33.6 million.

Non-GAAP operating loss was 1.2 million, which is an improvement of $2.3 million from the same quarter a year ago. Gap operating loss was 11.3 million. Non-gap net loss was 1.1 million, or two cents per diluted share. gap net loss was 11.2 million or 23 cents per diluted share. Moving now to slide seven, free cash flow in the quarter was negative 2.1 million, primarily reflecting the timing of customer payments. We ended the quarter with 120 million in cash, cash equivalents and investments, and no financial debt, which includes the completion of our ATM program. Now turning to our outlook for Q4 and full year 2026, please refer to slide eight. For Q4 2026, we expect ACV plus royalties of 103 million to 107 million. revenue of 25.7 million to 26.7 million. non-GAAP operating income of negative 0.9 million to positive 1.1 million.

As we look to finishing a strong 2026 for Arctrus, we see continued strength in semiconductors. Consequently, we are raising our full year guidance on revenue, ACV plus royalties, and non-GAAP operating income. For the full year 2026, our guidance is as follows. ACV plus royalties to exit 2026 at 103 million to 107 million, an increase of 1 million from prior guidance. revenue of 98.5 million to 99.5 million, and increase of 2.5 million from prior guidance. non-GAAP operating loss of between 9.2 million to 7.2 million, an improvement of 0.3 million from prior guidance. non-GAAP free cash flow of positive 5 million to positive 9 million unchanged from prior guidance. We are encouraged by the continued license activity and ongoing customer engagement. We remain focused on execution and on managing expenses carefully as we work toward improving operating leverage. With that, I'll turn the call back to the operator for the Q&A.

Operator

Thank you. Ladies and gentlemen, we will now begin the question and answer session. Should you have a question, please press the star followed by the one on your touchtone phone. You'll hear a prompt that your hand has been raised. Should you wish to decline from the polling process, please press the. star followed by the two. If you are using a speakerphone, please lift the handset before pressing any keys. Please limit your questions to one question and one follow-up question to allow enough time for others in the queue. Individuals can re-enter the queue if needed.

One moment, please, for your first question. Your first question comes from Kevin Garrigan with Jefferies. Please go ahead.

分析師問答

Kevin Garrigan

Yes. Hey, Charlie and Saurabh. Congrats on the results. And Saurabh, welcome to the Arteris party. Hey, can you quantify the economics of the multi-product adoption? How much larger is the average contract when a customer takes the NOC system integration and security product together versus... you know, just taking a single product agreement.

Karel Janac

Yes, so as we said, so when we went public back in 2021, that by 2026, which is this year, we'll be at about about $1 million ASP on the network on chip. If you throw in the Magilem and the Psycuity products, probably looking at something for an additional 400,000 maybe for 450 something like this and so if you take everything from us you would probably be somewhere around 1.4 1.5 million.

Kevin Garrigan

Got it. Got it. Okay. That makes sense. And then your licensing agreements with the U.S. hyperscaler and the two leading-edge semiconductor companies, can you just describe the applications, whether these are for training, inference, networking, or custom silicon? And is it different than, I guess, are the applications different than what they were previously using before?.

Karel Janac

Are tariffs for? No, they're the same. So basically they are custom silicon for AI inference. Okay.

Operator

Got it. Okay, perfect. Thanks, guys, and congrats again on the results. Thank you. Thank you. Your next question comes from Kevin Cassidy with Rosenblatt. Please go ahead.

Kevin Cassidy

Yes, thanks for taking my question, and I also welcome Saurabh. And congratulations on the milestone of 1,000 customers. When you're moving into the physical AI or expanding on the physical AI, it seems like that's a great opportunity. How much different are these designs than, say, what was in automotive or in data center?.

Karel Janac

So the physical AI actually looks, have significant similarities to automotive. You need functional safety, you need security, you need power efficiency, and you need performance. So, you know, The experience that we have in automotive translates directly to physical AI. In fact, I would argue that a car eventually will become basically a robot on wheels. Basically, the automated driving vehicles are basically applications of physical AI to transportation. There are some differences. There is a greater emphasis on sort of microcontroller functions and be able to handle motion control of the various motion axes and those kinds of things and also some additional sensor processing capability, but there's actually quite a bit of similarity.

Kevin Cassidy

Okay, great. You've got good experience already. And, you know, also we're seeing the trend of the... smaller physical AI companies getting acquired by even large analog companies or either other large microcontroller companies. What happens with your license agreements if there's a merger of two of your customers?.

Karel Janac

So all of our contracts have assignment provisions. And so it's a subject of discussion where we do not unreasonably withhold assignment of the contracts, but the assignment of the contracts using our technology is not automatic.

Kevin Cassidy

Okay, great. All right, thank you. Congratulations on good progress towards profitability, too. Thanks.

Operator

Thank you. Your next question comes from Joshua Buchalter with TD Cowen. Please go ahead.

Joshua Buchalter

Hey guys, thank you for taking my questions and echoing the welcome to SORAB. You know, maybe Kevin teed me up for one. You know, now that your guidance is implying sort of operating profitability in the fourth quarter, you know, how should we think about leverage from here? I mean, you guys have a lot of irons on the fire, but have held off pretty flat the last few quarters. You know, what's the sort of the right trajectory as we think about comparing OpEx growth to revenue growth from here? Thank you.

Saurabh Sinha

Yes, I'll take that Charlie. So Josh, as I mentioned in my prior remarks, our model is operating expenses to grow at half the rate of our revenue growth and which we have demonstrated in this quarter as well. So that is the trajectory we are on. the operating expenses we have very good visibility on it and we expect to, and that is why we raised our guidance for Q4.

Joshua Buchalter

Thank you for the color there. And then to follow up, I mean, you highlighted a few times, you know, seeing more traction in multi-die chiplet offerings. Any way you can help us with context of how much of the revenue base today is coming from, you know, FlexBGEN and Amkor solutions for multi-die?.

Karel Janac

Thank you. So we don't break this out individually, but right now, chiplet designs are about 10% of all designs. We think that ultimately that grows to about maybe 30, 35% of all designs. So it will be a significant contributor to our revenue growth. The thing that should be noted though is that the chiplet designs are basically Each chiplet is a project and each chiplet is a royalty stream. And so the chiplet projects have basically significantly higher ASP than single die projects. So we're very excited about the technology. The data movement schemes of chiplet designs are much more sophisticated. and valuable, and so we think that chiplets represent a significant opportunity for Arteris going forward, and we're already in a significant number of chiplet designs.

Thank you for the color there, Charlie. Really interesting. Helpful again. Thank you.

Operator

Your next question comes from Martin Yang with Oppenheimer. Please go ahead.

Martin Yang

Thank you for taking my question. Again, welcome, Saurabh. First question on the ACV plus royalties. This quarter, the incremental growth sequentially is moderating relative to the prior quarters. Is there anything worth pointing out there, any movement.

Saurabh Sinha

that you could give us more details. Thank you. Yeah, Martin. So, I mean, we look at on a year-over-year basis and we have shown steady growth in ACV and royalties. If you look at our revenue growth, that has been also excellent. And we have guided up for Q4 as well. We did beat Q3, top end of the range. So it is all about... looking at a snapshot at a point in time and there is some lumpiness which happens due to timing of the deals but we feel pretty confident about and that is why q4 is being guided up.

Martin Yang

Got it. Thank you, Farah. Another question on security. I was curious if you have an updated view on your go-to-market approaching customers outside of government contracts, which are longer-term vision for security comparing to what it is today.

Karel Janac

Yes, I mean, cybersecurity is becoming much more important and much more top of mind issues for customers, both on the government side and the commercial side. Last quarter, we announced a deal with ARM for use of security on their A-class cores. This time, we announced We've also announced a deal with BAE and Sci-5 for a trusted initiative. This is more of a government side. But obviously over time our goal is to take our security more and more into the commercial accounts where we have a significant presence. You know, security takes a while to adopt, but we're very encouraged with the progress that we're seeing. Thank you, Charlie. That's it for me.

Operator

Thank you. Ladies and gentlemen, as a reminder, if you have a question, please press star one. Your next question comes from Suji Da Silva with Roth Capital Partners. Please go ahead.

Sujeeva De Silva

Hi, Charlie and Saurabh, best of luck in the new role here. Staying on the chiplet topic, Charlie, maybe you could talk about, you said it's their each one project for these multi-chip. versus this monolithic die, maybe you can give us some sense of kind of the ratio of how many projects you're seeing as we break out the chiplets versus the traditional monolithic die programs. And if it's kind of an X multiplier or if there's some bundling in there.

Karel Janac

Well, I mean, it's a subject of negotiation, right? You know, if you have five or six chiplets in a package, right, There's a discussion with a customer about what is the discount on each project, right? It's not a basically one X multiplier for each chiplet, but we and other companies in the industry are establishing a model that each chiplet in the package has its own project price and its royalty. those projects are pretty prevalent or more prevalent in the data center, because they're, they're, they're basically used for the AI training and inference workloads. And, you know, those are, those are big complex projects, with much, much higher ASPs. And, I think right now, as far as what we're seeing, is about 10% of the license of the design starts are chiplets. We think that over the next two to three years, it's going to grow to perhaps 35% or maybe even more. Obviously, the data movement architecture of those kinds of chips. You not only have to handle the on-die data movement, but you also have to handle the multi-die data movement. And so things get much more valuable and much more complex, and it's an opportunity for us to add value So we're very excited about the chiplet-type projects.

Sujeeva De Silva

Yeah that's great color Charlie thanks and then just one question to sort of throw out there I mean you may be seeing some early humanoid robotics projects versus automotive projects, any sense of how many more design win opportunities are for you, just you know on some sample examples out of the gate here to get some idea of a ratio of kind of a robotics opportunity versus automotive droid versus an automobile, how many, what the ratio there might be?.

Saurabh Sinha

Yes, so Sujit, we are well diversified from a customer base and application standpoint. So no one customer has accounted for more than 10% of our revenue in the last few quarters. And we are also diversified by geography as well, along with the application. So automotive, yes, and ADAS is important for us, but there are other applications as well which are shaping up equally well. Okay. All right. Thanks guys.

Operator

Thank you. Ladies and gentlemen, that concludes today's Q&A session. I will turn the call back over to Charlie Janik.

Karel Janac

Well, thank you for joining our call today and for your interest in Arteris. Thank you for all the questions. And we look forward to updating you on our business progress in the quarters ahead and in the coming up investor conferences. So thank you for your support.

Operator

Ladies and gentlemen, this concludes today's conference call. Thank you for participating. You may now disconnect.

This live transcript is auto-generated without human intervention or review.

[Call has ended.]

This live transcript is auto-generated without human intervention or review.

本文部分內容由 AI 生成和翻譯,並經人工審核,僅供參考且做為一般資訊用途,不構成投資建議。

免責聲明:本網站提供的資訊僅供教育和參考之用,不應視為財務或投資建議。

推薦文章

tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有